INTRODUCTION
The sulphated glycosaminoglycans (GAGs) usually occur in the tissues as proteoglycans, in which the GAG chains are covalently bound to a core protein (for a review, see Kjellen and Lindahl, 1991) . Heparan sulphate (HS) proteoglycans, abundant on cell surfaces and in the extracellular matrices of most tissues, have attracted particular attention due to the propensity of HS chains for binding to proteins. HS has thus been implicated in a variety of interactions with proteins of manifest or alleged functional importance. The physiological or pathophysiological significance of such interactions have been the subject of much speculation.
While the aetiology of Alzheimer's disease (AD) remains unclear, its neuropathological features are fairly well defined. Amyloid deposits are associated with the typical lesions, i.e. senile plaques and neurofibrillary tangles, and are also found in the vascular walls. The predominant constituent of senile plaques has been identified as the 40-43 amino acid residue ,-amyloid protein (also referred to as A, ; Husby et al., 1993) . The /1-protein is the proteolytic-cleavage product of a larger amyloid precursor protein (APP; 365-770 amino acids in various isoforms, corresponding to alternatively spliced exons) (for reviews see Glenner, 1988; Kosik, 1992) .
Numerous reports have indicated the occurrence of GAGs/ proteoglycans in AD lesions (Snow et al., 1988; Snow and Wight, 1989; Perry et al., 1991; Kisilevsky, 1992; Su et al., 1992) . Immunohistochemical evidence particularly implicates the HS proteoglycan 'perlecan' (Snow et al., 1994a,b) . Curiously, the core proteins of both HS (Schubert et al., 1988 ) (however, see Gowda et al., 1989) and, more recently, chondroitin sulphate (CS) (Shioi et al., 1992) proteoglycans were claimed to be strongly related or identical to the APP itself. The ubiquitous distribution of HS proteoglycans (Herndon and Lander, 1990; Margolis and Margolis, 1993) and their functional involvement with important processes such as neurite outgrowth (Raulo et al., disaccharides by anion-exchange h.p.l.c. yielded four mono-Osulphated and one di-O-sulphated disaccharide; these components occurred in strikingly similar proportions in all cerebral HS preparations (except polysaccharide from neonatal brain) irrespective of the age of the individual and the histopathology of the cortex specimen. No significant difference was noted between HS obtained from control and from AD tissue. By contrast, the composition of HS isolated from brain differed significantly from that of HS preparations derived from other human organs. 1994) and Schwann cell proliferation (Ratner et al., 1988) have further focused attention on this type of proteoglycan in relation to AD. A 'consensus sequence' for heparin/HS binding (Cardin and Weintraub, 1989) has been identified corresponding to residues 12-17 of the A, peptide, and interaction with the sulphate substituents of GAG chains is believed to influence the aggregation behaviour of the peptide (Fraser et al., 1992) . Indeed, it has been speculated that altered binding properties due to deranged sulphation of HS may be a primary cause of the disease (Zebrower and Kieras, 1993) . However, little is known regarding the structure of HS GAG from human brain, let alone the correlation to AD. The present study was initiated in order to obtain such information. Iverius, 1971) was provided by W. Murphy, University of Monash, Melbourne, Australia. Unlabelled standards of hyaluronan, CS and heparin were as described by Enerback et al. (1985) . Escherichia coli K5 capsular polysaccharide was given by K. Jann, Max-Planck-Institut fur Immunbiologie, Freiburg, Germany.
MATERIALS AND METHODS

Methods
Isolation of polysaccharides
The isolation of GAGs from tissue specimens was performed according to a modification of the procedures of Singh and Bachhawat (1968) 
N-[3H]Acetyl-labelling of polysaccharides
Chondroitinase-resistant polysaccharide fractions were N-[3H]acetyl-labelled, in essence according to the procedure of Hook et al. (1982) . Samples (corresponding to 10-20,tg of hexuronic acid) were partially N-deacetylated by treatment for 30 min at 96°C with 500 ,ul of hydrazine, containing 30 % (v/v) water and 1 % (w/v) hydrazine sulphate (Guo and Conrad, 1989) . The products were repeatedly evaporated to dryness after addition of toluene, and the polysaccharide was then reisolated either by gel chromatography on a column (1 x 90 cm) of Sephadex G-1 5 in 10 % aqueous ethanol or by extensive dialysis against water. After freeze-drying, the partially N-deacetylated material was dissolved in 100 ,ul of 0.05 M Na2CO3, containing 10 % (v/v) methanol. A total of 4 mCi of [3H]acetic anhydride was added intermittently over 1 h, while the pH was kept at 7.0 by additions of 10 % methanol saturated with Na2CO., and was followed by 5 consecutive additions of 10 ,1u of unlabelled acetic anhydride during an additional 1 h period. The mixture was applied to a column (1 x 12 cm) of Sephadex G-15, eluted with 0.5 M sodium acetate/I M NaCl. The labelled, excluded material was pooled and dialysed against two changes of 0.5 M sodium acetate/I M NaCl followed by several changes of water. The product was freeze-dried to dryness [specific activity (0.5-1) x 106 c.p.m. 3H/,tg hexuronic acid; however, see heterogeneity of product in the Results section].
Compositional analysis of HS Deamination of polysaccharide, resulting in cleavage at Nsulphated 2-amino-2-deoxy-D-glucose (GlcN) units, followed by reduction of the products with NaB3H4, was used to determine the composition of HS preparations (Bienkowski and Conrad, 1985; Pejler et al., 1987 the incorporation of 3H could be ascribed to the specific cleavage process. The more elaborate dual-reduction procedure was applied to selected samples of HS that contained potentially reducible impurities, such as material solubilized by alkali treatment from protease-resistant tissue residues. The 3H-labelled di-and oligo-saccharides were first separated in one pool from smaller labelled compounds on a column (1 x 170 cm) of Sephadex G-15 in 0.2 M NH4HC03. This pool was subsequently fractionated into di-, tetra-and larger oligo-saccharides on a somewhat longer column (1 x 200 cm) under similar conditions. Pooled fractions were desalted by freeze-drying. The disaccharides were separated further by anion-exchange chromatography on a Partisil-1O SAX column (Whatman), connected to a model Flo-One HS radioactive-flow detector, as described by Pejler et al. (1987 
RESULTS
Isolation of polysaccharides Samples of HS were isolated from cerebral cortex of patients with clinical diagnosis of AD and characteristic neuropathology, and from control subjects. Defatted cortex was subjected to proteolytic digestion and the digests were fractionated by anionexchange chromatography (Procedure A, see Methods section). Carbazole-positive material emerged in two major peaks of about equal size, the less retarded of which appeared at the same elution position as HA (results not shown). Fractions appearing after the HA peak were pooled, desalted and digested with chondroitinase ABC and nuclease. A resistant HS fraction was separated from the resultant CS or dermatan sulphate (DS) oligosaccharides by gel chromatography (results not shown).
The yields of the various GAGs, as assessed from these relatively crude analyses, showed appreciable variability between samples (Table 1) . While a larger number of observations would be required to establish any correlation between GAG contents and the disease state, the data are compatible with slightly increased overall polysaccharide contents in afflicted tissue. The yield of HS averaged -100 ug of hexuronic acid per gram of dry defatted cortex, the AD samples tending to give somewhat higher values (see also Jenkins and Bachelard, 1988) . The interpretation of these results is complicated by the fact that the tissue specimens analysed on a column (1 x 100 cm) of Sephadex G-100, eluted with 1 M NaCI and effluent fractions were analysed for radioactivity or for hexuronic acid using the carbazole method. 
Purification of HS
To obtain structural information of the HS present in normal versus diseased cortex the alleged HS fractions were radiolabelled by N-deacetylation (through hydrazinolysis) followed by re-N-[3H]acetylation (see Methods section and Figure 1 ). Unexpectedly, only part of this material was susceptible to digestion with bacterial heparitinase, a major labelled macromolecule remaining virtually unaffected by the enzyme (Figure 2a ). The occurrence in the 'HS' fraction of two distinct 3H-labelled polysaccharide species, as suggested by this finding, was verified by anion-exchange chromatography on DEAE-Sephacel, using a shallow salt-gradient, which yielded two major, almost completely separated peaks of 3H-labelled material (Figure 2b ). The more retarded of these components (designated HS in Figure  2b) Figure 2b ) from (a) preparation 3pAD; and (b) preparation 4pC, were deaminated with HNO2 (pH 1.5 procedure) and the products were subjected to gel chromatography on a column (1 x 200 cm) of Sephadex G-50 (superfine) eluted with 1 M NaCI (0, *); (a) also shows a chromatogram of sample 3pAD before deamination (A\). The figures above the oligosaccharide peaks in (a) indicate the number of monosaccharide units per molecule. This assignment was based on calibration of the column with oligosaccharides, obtained from E coil K5 capsular polysaccharide by partial N-deacetylation (hydrazinolysis as described in the Methods section, for 15 min) followed by deamination at pH 3.9 (Shively and Conrad, 1976) . The resulting even-numbered oligosaccharides were detected by the carbazole reaction (results not shown).
Figure 4 Size-distribution of N-acetylated regions In cerebral HS Samples of N-[3H]acetyl-labelled HS (corresponding to fraction HS in
ion-exchange chromatography afforded a product that was susceptible to digestion with bacterial heparitinase (results not shown) and to degradation with nitrous acid (pH 1.5 procedure), as evidenced by gel chromatography of intact and deaminated HS (mixed with N-[14C]acetyl-labelled bovine kidney HS standard) (Figure 3a) . A gel chromatogram of undegraded HS, purified from control brain (Figure 3b ), did not differ significantly from that of AD HS (Figure 3a) . The peak elution position of the cerebral HS preparations coincided approximately with that of commercial heparin (Mr-12000) from pig intestinal mucosa (Figure 3b ). These findings indicate that the HS species derived from normal and from AD brain were of roughly similar charge, density and molecular size. The less retarded fraction (designated KS in Figure 2b ) was found to be degradable by Pseudomonas 1,4,-/J-D-galactanohydrolase (keratanase), suggesting that it is a sulphated poly-N-acetyllactosamine (low-sulphated keratan sulphate) (results not shown). The KS fraction was not analysed further.
Structural analysis of HS
Information regarding the distribution of N-acetyl groups in purified HS was obtained by gel chromatography of oligosaccharides, generated by deaminative cleavage of N-[3H]acetyllabelled polysaccharide at the sites of (isolated or consecutive) N-sulphated disaccharide units (see Figure 1) . While the intact polysaccharides were partly excluded from Sephadex G-50 The HS constituents of samples (a) 2pC and (b) 6oAD, were degraded by HNO2/NaB3H4 treatment (see Figure 1 ) and the resultant 3H-labelled oligosaccharides were separated by gel chromatography on Sephadex G-15, as described in the Methods section. Effluent fractions were pooled as indicated by the horizontal brackets in (a) and were analysed further as described in the text. (c) Ratios of 3H-labelled disaccharides/total saccharides obtained by HNO2/NaB3H4-treatment of HS from control or AD specimens. The disaccharide peaks of chromatograms similar to those shown in (a) and (b) were related to the corresponding overall elution profiles. One of the control samples is derived from neonatal brain. The AD samples were from 13 analyses of separate HS preparations (shown in the right-hand column) from four different patients (3, 5, 6, 11) . The data in the middle column include only one sample from each patient and refer in each case to cortex samples showing the highest density of senile plaques.
( Figure 4a ) the deamination products yielded distinct patterns of labelled oligosaccharides that extended from a predominant tetrasaccharide peak over a series of even-numbered, essentially equi-abundant 6-to 16-saccharides, to a slight accumulation of larger, 18-to -24-mers. The chromatograms relating to AD (Figure 4a groups was obtained by analysis of 3H-labelled disaccharides and larger oligosaccharides generated by HNO2/NaB3H4-treatment of unlabelled HS fractions (see Methods section and Figure 1 ). The HS preparations yielded labelled disaccharides and larger oligosaccharides from (-GlcNS03)-HexA-GlcNSO3-and (-GlcNSO3)-HexA-[GkcNAc-GlcA]> 1-GlcNSO3-sequences, respectively, in the intact polysaccharides (see Figure 1) . The proportions of these components varied somewhat, as illustrated for two samples in Figures 5(a) and 5(b). Compiling these data for all cerebral HS preparations analysed, revealed a broader range of N-sulphate: N-acetyl molar ratios for the AD as compared with control polysaccharides, as reflected by the proportions of disaccharide deamination products (Figure 5c ). This finding suggests an over-representation of more highly N-sulphated HS in AD brain.
The HexA-GlcNAc-GlcA-[l-3H]aManR (aManR = 2,5-anhydro-D-mannitol formed by reduction of terminal 2,5-aMan residues, deamination products ofN-sulphated glucosamine units in the intact saccharide) tetrasaccharides were analysed with regard to 0-sulphate contents by high-voltage paper electrophoresis at pH 1.7 (see Methods section; electropherograms not shown). No difference was noted between AD and control HS. For example, the relative proportions of non-sulphated, mono-O-, di-0-and tri-O-sulphated tetrasaccharides derived from 3pAD HS were 31, 50, 15 and 5%, whereas the corresponding values for 4pC HS were 35, 47, 14 and 4 % respectively.
[Samples of HS from cerebral cortex are designated by a running number, the origin of the sample (f, frontal; p, parietal; o, occipital, t, temporal region) and an indication of AD or control (C) status.]
The labelled HexA-[l-3H]aManR disaccharides were separated further by anion-exchange h.p.l.c. (Figure 6 ) into non-sulphated species (not determined), four different mono-O-sulphated disaccharides (the 0-sulphate groups are indicated in parentheses) [GlcA(2-OSO3)-aManR, GlcA-aManR(6-OS03), IdoA-aManR(6-OSOI), IdoA(2-OS03)-aManR] and a di-O-sulphated disaccharide (IdoA = L-iduronic acid). The di-O-sulphated component derived from cerebral HS was identified as IdoA(2-OSO3)-aManR(6-OS03), since IdoA-aManR(6-OS03) and IdoA(2-OSO3)-aManR were the only mono-O-sulphated disaccharide products found in significant amounts after mild acid treatment [0.2 M trifluoroacetic acid, 100°C, 30 min; results not shown (see Kusche et al., 1988) ]. All samples derived from adult brain HS (altogether 13 separate preparations; Table 2 ) yielded strikingly similar patterns, with predominant peaks of GlcA- (Figure 6c ; Table 2 ). The AD polysaccharide preparations studied were derived from whole, unfractionated cerebral cortex with a variable load of senile plagues, but not specifically from amyloid deposits. Also, cortex from predilection sites, such as the hippocampal region, could not be selectively recovered on dissection of the specimens. It could therefore be argued that a specific subpopulation ofHS, selectively associated with the AD lesion, might have escaped detection. Microscopic examination of the material remaining insoluble after proteolytic digestion of defatted AD cortex showed the presence of some residual amyloid fibrils. Alkaline extraction ofsuch material (see Methods section) yielded GAG fractions corresponding to total hexuronic acid contents ranging from -10 to -60,ug per g of dry, defatted starting material. However, the labelled disaccharides obtained on analysis of this polysaccharide by the NaBH4/HNO2/NaB3H4 procedure did not differ significantly from those obtained from the proteolytically solubilized HS fractions (Table 2) .
Contrary to the disaccharides generated by deamination of the multiple HS preparations from brain, the corresponding components derived from human kidney (Figure 6d ), liver ( Figure  6e ) and aorta ( Figure 6f ) HS yielded markedly different h.p.l.c.
profiles. While all chromatograms, similar to those of the brainderived HS disaccharides, showed a predominant IdoA(2-OS03)-aManR peak the relative amounts of the various disaccharide components diverged between each one of the samples, including the 'average' brain pattern ( Figure 6 ; Table 2 ).
DISCUSSION
Proteoglycans exert their biological functions primarily by interacting, through their GAG moieties, with other macromolecules, mostly proteins (Jackson et al., 1991; Kjellen and Lindahl, 1991) .
Such interactions, generally ionic in nature, depend on the distribution of negative charges along the polysaccharide chains and can be highly specific, as illustrated by the antithrombinbinding region in heparin and HS (see Kjellen and Lindahl, 1991, for references) . In other instances binding is less selective and involves cooperative electrostatic interaction rather than defined binding regions. HS, which is produced by virtually every type of cell investigated, displays the highest level of structural complexity of all GAGs, presumably reflecting its diverse functional requirements involving binding of different protein ligands. HS is produced by an elaborate biosynthetic machinery, the regulation of which, as required to generate different saccharide sequences, is only partly understood (Lindahl, 1989; Lidholt and Lindahl, 1992) . Conversely, surprisingly little is known concerning the topological variability of HS structures in the various organs and tissues of the body.
HS (or heparin) has been shown to interact with a number of proteins of established or potential functional importance to the nervous system. Such ligands include /-amyloid peptide (Brunden et al., 1993) , N-CAM (Cole et al., 1986) , acetylcholinesterase (Brandan et al., 1985) , basic fibroblast growth factor (Rapraeger et al., 1991) , laminin (Martin and Timpl, 1987) , protease nexin 1 (Farrell and Cunningham, 1987) , heparinbinding growth-associated molecule (Raulo et al., 1994) and amphoterin (Parkkinen et al., 1993) . The structural requirements for these interactions, in terms of saccharide sequence, have not been established. We are therefore intrigued by the striking compositional uniformity of HS preparations isolated from human cerebral cortex. This characteristic appears to be independent of the origin of the cortex specimen and, for adults-, the age of the patient; the neonatal torain shows a conspicuous lack of one particular disaccharide unit. By contrast, the composition of the cerebral HS deviates markedly from those of HSs from other human organs, as shown in particular on analysis of disaccharide deamination products. Other recent studies likewise point to distinctive structural properties of HS isolated from a particular organ (Lyon et al., 1994) . It is possible that the data for brain HS reflect a composite pattern, contributed by several different polysaccharide species, in which case the various HS species would have to occur in remarkably constant ratios. The identification of proteins capable of specific (or preferential) interaction with HS from cerebral cortex would obviously be of prime importance.
Is HS proteoglycan implicated in the pathogenesis of AD? Of particular interest is the report of Wagner et al. (1989) pointing to dramatically lowered amounts of protease-nexin 1 in afflicted regions of brains from AD patients as compared with controls. HS proteoglycan has been ascribed an important role in regulating the activity of this proteinase inhibitor (Farrell and Cunningham, 1987) . Our results do not exclude that this or other effects of HS may be perturbed in AD. Functional abberations might be considered in relation to the slight elevation in Nsulphation noted for some of the AD cerebral HS preparations in the present study. However, the findings do not support the proposal of a primary structural change in the HS molecule, caused by altered control of O-sulphotransferases in HS biosynthesis (Zebrower and Kieras, 1993) , as a causative factor in AD. On the other hand, it seems likely that overproduction of the amyloid fl-protein, for whatever reason, may lead to the formation of ,-protein-HS complexes, with secondary effects on vital HS functions. It should be important therefore to study in some detail the mode of interaction between the f-protein and the particular HS species occurring in human brain, and to define the functional consequences of such interaction.
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